Spire Healthcare Group PLC
LSE:SPI

Watchlist Manager
Spire Healthcare Group PLC Logo
Spire Healthcare Group PLC
LSE:SPI
Watchlist
Price: 164.4 GBX 0.86% Market Closed
Market Cap: £662.1m

P/FCFE

21
Current
34%
More Expensive
vs 3-y average of 15.6

Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.

P/FCFE
21
=
Market Cap
GBX660.5m
/
Free Cash Flow to Equity
£31.5m

Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.

P/FCFE
21
=
Market Cap
GBX660.5m
/
Free Cash Flow to Equity
£31.5m

Valuation Scenarios

Spire Healthcare Group PLC is trading above its 3-year average

If P/FCFE returns to its 3-Year Average (15.6), the stock would be worth GBX122.28 (26% downside from current price).

Statistics
Positive Scenarios
0/4
Maximum Downside
-99%
Maximum Upside
No Upside Scenarios
Average Downside
65%
Scenario P/FCFE Value Implied Price Upside/Downside
Current Multiple 21 GBX164.4
0%
3-Year Average 15.6 GBX122.28
-26%
5-Year Average 13.1 GBX102.83
-37%
Industry Average 0.3 GBX2.21
-99%
Country Average 0.2 GBX1.6
-99%

Forward P/FCFE
Today’s price vs future free cash flow to equity

Not enough data available to calculate forward P/FCFE

Peer Comparison

All Multiples
P/FCFE
P/E
All Countries
Close

Market Distribution

Higher than 95% of companies in United Kingdom
Percentile
95th
Based on 1 918 companies
95th percentile
21
Low
0 — 0.1
Typical Range
0.1 — 0.4
High
0.4 —
Distribution Statistics
United Kingdom
Min 0
30th Percentile 0.1
Median 0.2
70th Percentile 0.4
Max 901.8

Spire Healthcare Group PLC
Glance View

Market Cap
662.1m GBX
Industry
Health Care

Spire Healthcare Group PLC, a notable player in the UK’s independent hospital sector, operates an extensive network of private hospitals and clinics. Born out of Bupa’s acute care business in 2007, the company has carved a niche by offering a wide array of medical services, including elective surgeries, diagnostic tests, and specialist consultations. Spire’s revenue model revolves around providing these healthcare services both to self-paying patients and those insured with private medical insurance. A considerable portion of its income is also derived from contracts with the National Health Service (NHS), where Spire steps in to help reduce the public healthcare system’s waiting times. This dual-source revenue model allows Spire to balance its operations among private and public healthcare sectors effectively. The company's operations are anchored in a commitment to quality care, which is pivotal in sustaining its reputation and patient trust. Each healthcare facility is equipped with cutting-edge medical technology and staffed by experienced healthcare professionals, ensuring high standards of treatment and customer service. Spire’s strategic focus on investing in medical infrastructure and skilled personnel enables it to deliver specialized services that attract a broad demographic, from routine procedures to complex surgeries. As the healthcare landscape evolves, Spire Healthcare continues to adapt, striving to expand its service offerings and affordable healthcare solutions, whilst ensuring its hospitals and clinics remain synonymous with clinical excellence and patient satisfaction. This strategy appears designed not just to maintain its market position, but to meet the increasing demand for diverse and comprehensive healthcare services in the UK.

SPI Intrinsic Value
325.71 GBX
Undervaluation 50%
Intrinsic Value
Price GBX164.4
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett